Key Regulatory Requirements and Guidelines for the Registration of a Drug in Canada
Abstract
Drug product registration is an important step in the process of a drug development from raw material to finished product to making it available to the public. Drug regulatory authorities play an important role in this process. Health Canada is the regulatory authority in Canada which manages the drug submission and approval of drug product in Canada. The guidelines from the Food and Drugs Act and Regulations for drug products are reviewed. An application to Health Canada (HC) to market a new drug in Canada is done by the sponsoring pharmaceutical company; the application typically includes animal data, chemistry and manufacturing data, and the results from clinical trials of various phases. The Therapeutic Products Directorate (TPD) is responsible for the regulation of prescription and non-prescription pharmaceutical (i.e. chemically synthesized) products and medical devices. The Common Technical Document for Registration of Pharmaceuticals for Human Use (International Conference on Harmonization [ICH] Topic M4) was adopted by Health Canada, in 2003, for use in the preparation of drug regulatory activities. Module 1 is region specific, while Modules 2, 3, 4, and 5 are intended to be common for all regions. A regional component is included in Module 3. The review of information provided in a well-structured regulatory activity will improve the efficiency of the screening and review of that regulatory activity.
Keywords: Health Canada, TPD, ICH, Drug Product, NDS
Cite this Article
Thomas Sharin, Dixit Mudit, Dixit Rohit, et al. Key Regulatory Requirem-ents and Guidelines for the Registration of a Drug in Canada. Research & Reviews: A Journal of Drug Formulation, Development and Production, 2015; 2(2): 28–37p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)
1. ________________
2. _______________
_3. ________________
4. ________________
The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
